摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,7-二氮杂螺[4.4]-3,8-壬二酮 | 947239-51-2

中文名称
2,7-二氮杂螺[4.4]-3,8-壬二酮
中文别名
——
英文名称
2,7-diazaspiro<4.4>nonane-3,8-dione
英文别名
2,7-diazaspiro[4.4]nonane-3,8-dione
2,7-二氮杂螺[4.4]-3,8-壬二酮化学式
CAS
947239-51-2
化学式
C7H10N2O2
mdl
MFCD11226906
分子量
154.169
InChiKey
GLUGRUJRPBFVMF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.6
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.714
  • 拓扑面积:
    58.2
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2,7-二氮杂螺[4.4]-3,8-壬二酮 在 lithium aluminium tetrahydride 、 sodium hydride 作用下, 以 四氢呋喃 为溶剂, 反应 1.5h, 生成 2,7-二苄基-2,7-二氮杂-螺[4.4]壬烷
    参考文献:
    名称:
    Quinolone antibacterial agents substituted at the 7-position with spiroamines. Synthesis and structure-activity relationships
    摘要:
    A series of fluoroquinolone antibacterials having the 7-position (10-position of pyridobenzoxazines) substituted with 2,7-diazaspiro[4.4]nonane (4b), 1,7-diazaspiro[4.4]nonane (5a), or 2,8-diazaspiro[5.5]undecane (6b) was prepared, and their biological activities were compared with piperazine and pyrrolidine substituted analogues. Most exhibited potent Gram-positive and Gram-negative activity, especially when side chain 4b was N-alkylated.
    DOI:
    10.1021/jm00170a035
  • 作为产物:
    描述:
    3,3-二氰基戊二酸二乙酯 氢气三乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 23.0h, 以32%的产率得到2,7-二氮杂螺[4.4]-3,8-壬二酮
    参考文献:
    名称:
    Quinolone antibacterial agents substituted at the 7-position with spiroamines. Synthesis and structure-activity relationships
    摘要:
    A series of fluoroquinolone antibacterials having the 7-position (10-position of pyridobenzoxazines) substituted with 2,7-diazaspiro[4.4]nonane (4b), 1,7-diazaspiro[4.4]nonane (5a), or 2,8-diazaspiro[5.5]undecane (6b) was prepared, and their biological activities were compared with piperazine and pyrrolidine substituted analogues. Most exhibited potent Gram-positive and Gram-negative activity, especially when side chain 4b was N-alkylated.
    DOI:
    10.1021/jm00170a035
点击查看最新优质反应信息

文献信息

  • NOVEL AZACYCLYL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
    申请人:SCHWINK Lothar
    公开号:US20090264403A1
    公开(公告)日:2009-10-22
    The invention relates to azacyclyl-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one azacyclyl-substituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the azacyclyl-substituted aryidihydroisoquinolinones of the invention and their derivatives as MCH antagonists.
    本发明涉及含氮杂环取代的芳基二氢异喹啉酮及其衍生物、其生理上可耐受的盐和生理功能衍生物、其制备方法、包含本发明中至少一种含氮杂环取代的芳基二氢异喹啉酮或其衍生物的药物以及将本发明中的含氮杂环取代的芳基二氢异喹啉酮及其衍生物用作MCH拮抗剂。
  • Kajtar, Marton; Hollosi, Miklos; Kinsky, Klaus, Collection of Czechoslovak Chemical Communications, 1982, vol. 47, # 3, p. 936 - 949
    作者:Kajtar, Marton、Hollosi, Miklos、Kinsky, Klaus、Majer, Zsuzsanna
    DOI:——
    日期:——
  • CULBERTSON, TOWNLEY P.;SANCHEZ, JOSEPH P.;GAMBINO, LAURA;SESNIE, JOSEPHIN+, J. MED. CHEM., 33,(1990) N, C. 2270-2275
    作者:CULBERTSON, TOWNLEY P.、SANCHEZ, JOSEPH P.、GAMBINO, LAURA、SESNIE, JOSEPHIN+
    DOI:——
    日期:——
  • KAJTAR, M.;HOLLOSI, M.;KINSKY, K.;MAJER, Z., COLLECT. CZECH. CHEM. COMMUN., 1982, 47, N 3, 936-949
    作者:KAJTAR, M.、HOLLOSI, M.、KINSKY, K.、MAJER, Z.
    DOI:——
    日期:——
  • AZACYCLYL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
    申请人:SANOFI
    公开号:EP1987020B1
    公开(公告)日:2012-10-03
查看更多

同类化合物

8-氧代-2,7-二氮杂螺[4,4]壬烷-2-甲酸叔丁酯 7-苄基-2,7- 二氮杂螺[4,4]壬烷-3-酮 6-氧代-2,7-二氮杂螺[4,4]壬烷-2-甲酸叔丁酯 2-甲基-7-苄基-2,7-二氮杂螺[4.4]壬烷 2-甲基-7-苄基-2,7-二氮杂螺[4.4]-1,3,8-壬三酮 2-甲基-2,7-二氮杂螺[4.4]壬烷-1,3,8-三酮 2-甲基-2,7-二氮杂螺[4.4]壬烷 2-氧代-1,7-二氮杂螺[4.4]壬烷-7-羧酸叔丁酯 2-乙基-7-苄基-2,7-二氮杂螺[4.4]壬烷 2-乙基-2,7-二氮杂螺[4,4]壬烷 2-BOC-2,7-二氮杂-螺[4.4]壬烷 2-(苯基甲基)-2,7-二氮杂螺[4.4]壬烷 2,7-二苄基-2,7-二氮杂-螺[4.4]壬烷 2,7-二氮杂螺[4.4]壬烷-2-羧酸 1,1-二甲基乙酯盐酸盐 2,7-二氮杂螺[4.4]壬烷-1,3,6,8-四酮 2,7-二氮杂螺[4.4]壬烷, 2-甲基-,双盐酸盐 2,7-二氮杂螺[4.4]壬烷 2,7-二氮杂螺[4.4]-3-壬酮 2,7-二氮杂螺[4.4]-3,8-壬二酮 2,7-二氮杂-螺[4.4]壬烷-1,3,8-三酮 1-苄基-1,7-二氮杂螺[4.4]壬烷-7-羧酸叔丁酯 1-苄基-1,7-二氮杂螺[4.4]壬烷 1-苄基-1,7-二氮杂-螺[4.4]壬烷二盐酸盐 1-甲基-1,7-二氮杂螺[4.4]壬烷 1,7-二氮杂螺[4.4]壬烷双盐酸盐 1,7-二氮杂螺[4.4]壬烷-7-羧酸叔丁酯 1,7-二氮杂螺[4.4]壬烷-1-羧酸 1,1-二甲基乙酯 1,7-二氮杂螺[4.4]壬烷 1,6-二氮杂-螺[4.4]壬烷-2,7-二酮 (9CI)-螺[1-氮杂双环[2.2.1]庚烷-7,3-吡咯烷] 4-((3-chloro-4-methoxybenzyl)amino)-2-(7-methyl-2,7-diazaspiro[4.4]nonan-2-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-formamide 3,3,8,8-tetramethyl-1,6-diaza-spiro[4.4]nonane-2,7-dione (R)-7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane dihydrochloride (S)-7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane dihydrochloride 7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane di-oxalate 2-(5-Ethynylpyridin-3-yl)-2,7-diazaspiro[4.4]nonane 2-(5-(Cyclopentyloxy)pyridin-3-yl)-2,7-diazaspiro[4.4]nonane 7-(5-Ethynylpyridin-3-yl)-1-methyl-1,7-diazaspiro[4.4]nonane 7-Methyl-1-(pyridin-3-yl)-1,7-diazaspiro[4.4]nonane 7-(6-Chloropyridin-3-yl)-1-methyl-1,7-diazaspiro[4.4]nonane 7-Methyl-1-(pyrimidin-5-yl)-1,7-diazaspiro[4.4]nonane 2-(6-Methoxypyridazin-3-yl)-2,7-diazaspiro[4.4]nonane 1-Methyl-7-(pyridazin-3-yl)-1,7-diazaspiro[4.4]nonane 7-(6-Methoxypyridazin-3-yl)-1-methyl-1,7-diazaspiro[4.4]nonane 7-Methyl-1,7-diazaspiro[4.4]nonane (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(7-(methylsulfonyl)-2,7-diazaspiro[4.4]nonan-2-yl)tetrahydro-2H-pyran-3-amine 2-(methylsulfonyl)-2,7-diazaspiro[4.4]nonane 2-ethyl-7-(phenylmethyl)-2,7-diazaspiro<4.4>nonane-1,3,8-trione 2-ethyl-2,7-diazaspiro<4.4>nonane-1,3,8-trione 7-Benzyl-2-cyclopropyl-2,7-diazaspiro[4.4]nonane